世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039796

感染性呼吸器疾患診断市場:規模、シェア、動向分析レポート、およびセグメント予測、2025〜2030

Grand View Research Inc.

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2025- 2030

発刊日 2024/10

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000039796

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

感染性呼吸器疾患診断の市場規模、シェア、動向分析:製品別 (機器、サービス、消耗品)、サンプル別 (血液、NPS)、用途別、技術別、最終用途別、地域別、セグメント予測、2025-2030

市場規模と動向

世界の感染性呼吸器疾患診断の市場規模は、2024年に545億8000万ドルと推定され、2025年から2030年にかけて5.3%のCAGRで成長すると予想されます。市場の主な推進要因には、結核や肺炎などの疾患の有病率の増加、診断技術の進歩、主要なプレーヤー間のパートナーシップとコラボレーションの増加などがあります。例えば、2023年2月、Thermo Fisher ScientificとMylab Discovery Solutionsは、多剤耐性結核、B型肝炎ウイルス、C型肝炎ウイルス、HIV、遺伝子解析(HLA B27) などの感染症の診断用検査キットをインドで開発・販売するパートナーシップを発表しました。このコラボレーションは、Thermo Fisherのグローバルな専門知識とMylabの国内製造能力を組み合わせて、高品質の検査ソリューションへのアクセスを拡大します。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Sample
1.2.3. Product
1.2.4. End Use
1.2.5. Application
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
3.2.1.2. Technological Advancement In Respiratory Disease Testing
3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
3.2.2. Market Restraint Analysis
3.2.2.1. High Prices Of Diagnostic Products
3.2.2.2. Presence Of Ambiguous Regulatory Framework
3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Instruments
4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Imaging Tests
4.5.2.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Respiratory Measurement Devices
4.5.3.1. Respiratory Measurement Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Other Instruments
4.5.4.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Consumables
4.6.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Services
4.7.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infectious Respiratory Disease Diagnostics Market: Sample Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Infectious Respiratory Disease Diagnostics Market: Sample Movement Analysis
5.3. Infectious Respiratory Disease Diagnostics Market by Sample Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Saliva
5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Nasopharyngeal Swabs
5.6.1. Nasopharyngeal Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Anterior Nasal Region
5.7.1. Anterior Nasal Region Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Blood
5.8.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
6.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Immunoassay
6.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Molecular Diagnostics
6.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Microbiology
6.7.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Other Technologies
6.8.1. Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
7.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. COVID-19
7.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Influenza
7.6.1. Influenza Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Respiratory Syncytial Virus
7.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Tuberculosis
7.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Streptococcus Testing
7.9.1. Streptococcus Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Other Respiratory Disease Testing
7.10.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
8.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Hospitals
8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Diagnostic Laboratories
8.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Pharmaceutical & Biotechnology Companies
8.7.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Physician Offices
8.8.1. Physician Offices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Other End-Users
8.9.1. Other End-Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/ reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Recent Developments & Impact Analysis by Key Market Participants
10.3. Company Market Share Analysis, 2024
10.4. Key Company Profiles
10.4.1. ABBOTT
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. F. Hoffmann - La Roche Ltd
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. THERMO FISHER SCIENTIFIC, INC.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. KONINKLIJKE PHILIPS N.V.
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. BIOMÉRIEUX SA
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. BIO-RAD LABORATORIES, INC.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. QUIDEL CORPORATION
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. CEPHEID
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. QIAGEN
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. SIEMENS HEALTHCARE GMBH
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 4. Global infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 5. Global infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 6. Global infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 7. Global infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 8. North America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 9. North America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 10. North America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 11. North America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 12. North America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 13. U.S. infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 14. U.S. infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 15. U.S. infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 16. U.S. infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 17. U.S. infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 18. Canada infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 19. Canada infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 20. Canada infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 21. Canada infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 22. Canada infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 23. Mexico infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 24. Mexico infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 25. Mexico infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 26. Mexico infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 27. Mexico infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 28. Europe infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 29. Europe infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 30. Europe infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 31. Europe infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 32. Europe infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 33. UK infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 34. UK infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 35. UK infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 36. UK infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 37. UK infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 38. Germany infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 39. Germany infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 40. Germany infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 41. Germany infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 42. Germany infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 43. France infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 44. France infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 45. France infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 46. France infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 47. France infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 48. Italy infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 49. Italy infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 50. Italy infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 51. Italy infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 52. Italy infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 53. Spain infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 54. Spain infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 55. Spain infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 56. Spain infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 57. Spain infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 58. Denmark infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 59. Denmark infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 60. Denmark infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 61. Denmark infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 62. Denmark infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 63. Sweden infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 64. Sweden infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 65. Sweden infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 66. Sweden infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 67. Sweden infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 68. Norway infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 69. Norway infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 70. Norway infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 71. Norway infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 72. Norway infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 73. Asia Pacific infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 74. Asia Pacific infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 75. Asia Pacific infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 76. Asia Pacific infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 77. Asia Pacific infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 78. Japan infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 79. Japan infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 80. Japan infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 81. Japan infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 82. Japan infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 83. China infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 84. China infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 85. China infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 86. China infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 87. China infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 88. India infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 89. India infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 90. India infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 91. India infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 92. India infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 93. Australia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 94. Australia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 95. Australia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 96. Australia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 97. Australia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 98. South Korea infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 99. South Korea infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 100. South Korea infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 101. South Korea infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 102. South Korea infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 103. Thailand infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 104. Thailand infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 105. Thailand infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 106. Thailand infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 107. Thailand infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 108. Latin America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 109. Latin America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 110. Latin America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 111. Latin America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 112. Latin America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 113. Brazil infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 114. Brazil infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 115. Brazil infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 116. Brazil infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 117. Brazil infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 118. Argentina infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 119. Argentina infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 120. Argentina infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 121. Argentina infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 122. Argentina infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 123. Middle East & Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 124. Middle East & Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 125. Middle East & Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 126. Middle East & Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 127. Middle East & Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 128. South Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 129. South Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 130. South Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 131. South Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 132. South Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 133. Saudi Arabia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 134. Saudi Arabia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 135. Saudi Arabia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 136. Saudi Arabia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 137. Saudi Arabia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 138. UAE infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 139. UAE infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 140. UAE infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 141. UAE infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 142. UAE infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 143. Kuwait infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 144. Kuwait infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 145. Kuwait infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 146. Kuwait infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 147. Kuwait infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Infectious respiratory disease diagnostics market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Infectious respiratory disease diagnostics market, Product outlook key takeaways 2024 & 2030 (USD Million)
Fig. 12 Infectious respiratory disease diagnostics market, Sample outlook key takeaways 2024 & 2030 (USD Million)
Fig. 13 Infectious respiratory disease diagnostics market, Technology outlook key takeaways 2024 & 2030 (USD Million)
Fig. 14 Infectious respiratory disease diagnostics market, Application outlook key takeaways 2024 & 2030 (USD Million)
Fig. 15 Infectious respiratory disease diagnostics market, End Use outlook key takeaways 2024 & 2030 (USD Million)
Fig. 16 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Other Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Saliva market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Nasopharyngeal Swabs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Anterior Nasal Region market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Blood market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Immunoassay market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Molecular Diagnostics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Microbiology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Other Technologies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 COVID-19 market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Influenza market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Respiratory Syncytial Virus market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Tuberculosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Streptococcus Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Other Respiratory Disease Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Diagnostic Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Physician Offices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Other End users market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 North America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 U.S. infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Canada infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Mexico infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Europe infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 UK infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Germany infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Spain infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Norway infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Denmark infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Sweden infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 China infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Japan infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 India infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Korea infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Australia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Thailand infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Latin America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Brazil infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Argentina infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Middle East and Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 South Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Saudi Arabia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 UAE infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Kuwait infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 List of key emerging company’s/Allergen disruptors/innovators

この商品のレポートナンバー

0000039796

TOP